Mediterranean herb with clinical evidence for chronic sinusitis and respiratory inflammation via carvacrol. Potent antimicrobial in lab and some clinical contexts. Species identity and carvacrol percentage determine therapeutic value.
Traditions: Greek medicine, European herbalism, Unani medicine, Mexican folk medicine
Multiple traditions agree on use.
Aerial parts used as infusion, decoction, steam inhalation, and poultice for respiratory complaints (colds, cough, bronchitis), digestive spasms, wound antisepsis, and parasite expulsion. O. dictamnus (Dittany of Crete) specifically documented by Dioscorides.
Herbal tea and tincture for cough, bronchitis, and digestive upset. Related species (sweet marjoram, dittany) recognized by EMA/HMPC for mild GI complaints. No EMA monograph exists specifically for O. vulgare itself.
Za'atar-type Origanum species used for respiratory complaints, digestive disorders, and as an antimicrobial/antiseptic via decoctions, steam inhalation, and poultices.
Digestive remedy, cough suppressant, menstrual regulator. Abortifacient use documented across multiple folk traditions — the historical basis for the modern pregnancy contraindication.
Oil of oregano's best clinical evidence is for chronic sinusitis — not the antimicrobial uses it's famous for. A 75-person RCT found oregano nasal spray outperformed fluticasone steroid, corroborated by a 47-RCT network meta-analysis ranking O. vulgare first among 18 herbal treatments for chronic rhinosinusitis. For respiratory inflammation, five RCTs using purified carvacrol (the oil's main active compound) consistently improved lung function and inflammatory markers. Antiparasitic and antimicrobial signals exist but remain uncontrolled. All evidence is preliminary — independent replication needed before clinical recommendations can be made.
75 adults with chronic rhinosinusitis without nasal polyps: oregano oil nasal spray reduced SNOT-22 symptom scores by 51.52 points vs 21.60 for fluticasone steroid and 11.84 for placebo. Single study, regional journal, needs independent replication.
47 RCTs across 18 herbal medicines: O. vulgare ranked #1 for improving symptoms and quality of life in chronic rhinosinusitis without nasal polyps. Evidence certainty: low by GRADE criteria.
23 asthmatic patients: carvacrol 1.2 mg/kg/day for 2 months improved FEV1, FVC, and peak expiratory flow vs baseline, and reduced hs-CRP and white blood cell counts. No adverse events reported.
33 moderate asthmatic patients: carvacrol 1.2 mg/kg/day for 2 months alongside standard medications reduced respiratory symptoms, improved pulmonary function tests, and lowered oxidative stress and inflammatory cytokines.
14 patients with stool-confirmed parasites: 600 mg/day emulsified oregano oil for 6 weeks cleared Entamoeba in 4/4 cases (100%) and Blastocystis in 8/11 cases (73%). Uncontrolled — no placebo group.
Softgel capsules are the most studied and most bioavailable form. Must specify ≥60% carvacrol on label — that's the active compound. Start at 150–300 mg/day with food. Calculate your dose: target carvacrol mg ÷ product carvacrol % = mg product needed.
Liquid oil in carrier (olive oil standard). NEVER consume undiluted essential oil — severe mucosal irritation. Check carvacrol percentage before calculating dose. Capsules are more convenient and better standardized.
Taste: Pleasantly herbal and aromatic, less intense than oil supplements. Familiar oregano flavor.
Traditional whole-herb preparation. Extracts phenolics (rosmarinic acid, flavonoids) but NOT the essential oil constituents — carvacrol and thymol are volatile and minimally present in a water infusion. Different mechanism from capsules or oil preparations.
40–60% ethanol extracts more essential oil than water. Traditional form, less standardized than capsules. Higher alcohol percentages improve carvacrol extraction.
For minor skin infections, insect bites, nail fungus. Patch test first on inner arm. Do NOT apply undiluted or near eyes. Dilute properly — the essential oil will cause skin irritation at higher concentrations.
Oil of oregano has a surprising clinical story: its strongest emerging evidence isn’t for the antimicrobial and antifungal uses it’s marketed for, but for chronic sinus congestion.
Strongest evidence:
Moderate signals:
What hasn’t been proven (despite the hype): H. pylori eradication, Candida overgrowth, antiviral activity, and immune system support all have compelling in vitro data or anecdotal reports. Controlled human trials are absent or inadequate. One 15-person uncontrolled case series reported 93% H. pylori clearance using a multi-herb blend — compelling signal, not clinical evidence [12].
The carvacrol issue: Much of the respiratory evidence uses purified carvacrol, not whole oregano oil. At the studied dose of 1.2 mg/kg/day, a 70 kg person needs ~84 mg carvacrol/day — equivalent to roughly 112–168 mg of oregano oil standardized to 50–75% carvacrol. This dose conversion makes the research directly applicable to high-carvacrol products, but irrelevant to products with unverified or low carvacrol content.
The herb has millennia of use. The oil supplement is a 1990s invention.
Ancient Greek medicine (Dioscorides, 1st century CE):
European phytotherapy (19th–20th century):
Unani and Arab medicine (9th–16th century):
Mexican folk medicine:
The gap between tradition and supplement: Traditional medicine used dried herb as infusions, decoctions, steam, and tinctures. The concentrated steam-distilled essential oil sold today never existed in these traditions. Modern oregano oil supplements inherit the traditional reputation by extrapolation — the two preparations have different compound profiles and different delivery mechanisms, and should not be conflated.
This is not optional. Which product you choose determines whether you’re taking the studied compound or essentially a cooking spice.
Common culinary oregano (O. vulgare subsp. vulgare) often contains less than 20% carvacrol. Greek oregano (O. vulgare subsp. hirtum) contains 60–86% [14]. A product made from the wrong subspecies may contain essentially no therapeutic carvacrol.
Required label information:
| Form | Best For | Notes |
|---|---|---|
| Softgel capsules | Sinusitis, respiratory, antiparasitic | Closest to studied preparations; measurable dose; no burn |
| Liquid oil in carrier | Flexible dosing; topical combination | Intense mucosal irritation if under-diluted; harder to dose |
| Herbal tea | Digestive support, tradition | Minimal carvacrol; different active compounds (phenolics) |
| Tincture | Full-spectrum herb support | Less standardized; more traditional |
Capsules (evidence-referenced starting points):
Calculate your dose: Divide target carvacrol (mg) by product carvacrol fraction.
Liquid drops: Minimum 1:4 dilution in carrier oil or juice. Never undiluted — essential oil burns mucosal tissue. 3–5 drops 1–3 times daily is the commercial convention; dose varies widely by product carvacrol concentration.
Herbal tea: 1–2 teaspoons dried herb per cup, covered steep 10–15 minutes, 1–3 cups daily. Does not deliver therapeutic carvacrol; indicated for traditional digestive and respiratory herb support.
Baseline (one week before starting):
During trial:
STOP immediately if:
Liquid oil of oregano drops have a reputation — earned. Undiluted or poorly diluted, the essential oil produces an intense, sustained burning sensation in the mouth, throat, and esophagus. This isn’t a sign it’s working. It’s carvacrol acting as a chemical irritant on mucous membranes at high concentration — the same mechanism that makes it antimicrobial in vitro also irritates tissue.
If using liquid drops: always dilute in carrier oil first, or take in juice. Capsules avoid the problem entirely and are better studied for clinical indications. The same principle applies topically — always patch test on the inner arm first, dilute to 1–2% in carrier oil (1–2 drops per teaspoon), and keep away from eyes, face, and broken skin.
The species problem is real. “Oil of oregano” supplements vary from ≥80% carvacrol therapeutic preparations to products made from common culinary oregano containing less than 20% carvacrol. The label alone won’t tell you unless subspecies and carvacrol percentage are stated.
Non-negotiable requirements:
Avoid:
Regulatory context: FDA classifies oregano as GRAS (generally recognized as safe) as a food flavoring — this covers culinary amounts, not supplement doses. Health Canada accepts it as a natural health product for antioxidant and digestive use. The EFSA established a no-adverse-effect level (NOAEL) of 200 mg/kg/day in 90-day rat studies — a safety margin of roughly 4,000x over typical dietary exposure, providing meaningful reassurance for standard supplement doses (150–600 mg/day) [14]. LiverTox rates it “unlikely to cause liver injury” — no cases documented in clinical registries [13].
Oil of oregano’s popular reputation centers on being a powerful natural antibiotic and antifungal. That reputation is partly supported by strong in vitro data — carvacrol does disrupt bacterial cell membranes and kill Candida in a dish. The human evidence for those uses is thinner than the marketing suggests.
What’s better documented is chronic sinusitis, where oregano outperformed a prescription nasal steroid in one trial and ranked first in a network meta-analysis. And for respiratory inflammation broadly, the carvacrol constituent RCT series provides consistent, if not yet independently replicated, evidence for benefit in asthma.
The biggest variable is product quality. Without O. vulgare subsp. hirtum and a verified carvacrol percentage ≥60–70%, you may be taking an herb with minimal therapeutic content — the bottle matters as much as the herb.
Worth trying if: You have chronic sinusitis that hasn’t responded fully to standard care, recurrent respiratory infections, or a confirmed parasitic gut infection, and you want a botanical option with emerging evidence behind it.
Be cautious if: You’re on anticoagulants, blood sugar medications, or have ever reacted to mint family herbs. Tell your prescriber.
Do not use if: You are pregnant or planning to become pregnant. This is the one firm line.
Start at 150–300 mg/day with food. Give it 4–8 weeks for the indication you’re targeting. If nothing is shifting after 8 weeks, it may not be the right tool — stop and reassess rather than escalating dose.
Duration: 4 weeks minimum for sinusitis (RCT duration). 2 months for respiratory and inflammatory goals (carvacrol RCT duration). Days to 2 weeks for acute digestive or antimicrobial use.
What to notice:
Start at 150–300 mg/day with food. The burning sensation from liquid drops is intense and normal — it's carvacrol acting as an irritant on mucosal tissue at concentration. Capsules avoid this completely and are better studied. Carvacrol percentage matters more than milligrams: a 500 mg capsule at 20% carvacrol delivers 100 mg carvacrol; a 150 mg capsule at 80% carvacrol delivers 120 mg. Always check the Certificate of Analysis.
Generally considered: safe
Contraindications:
Pregnancy/Nursing: Contraindicated in pregnancy — abortifacient traditional use is documented across Mediterranean, Arab, and Latin American folk traditions. Avoid medicinal doses during breastfeeding (insufficient data on infant carvacrol exposure). Small amounts as a culinary spice are not systematically studied at medicinal doses.
Generally well-tolerated short-term safety profile. LiverTox rates it 'unlikely to cause liver injury' (Score E) — no hepatotoxicity cases documented in clinical use or international DILI registries. GI side effects (heartburn, nausea, diarrhea) are the main concern, especially at higher doses; take with food and start low. Theoretical drug interaction with diabetes medications (in vitro blood glucose lowering) — monitor if on insulin or oral hypoglycemics. CYP2A6 interaction theoretically possible at chronic high doses, relevant to letrozole, efavirenz, nicotine metabolism. No pediatric safety data — avoid in children. Human safety data beyond 4 weeks for whole preparations is absent; the carvacrol Phase I trial established tolerability at 1–2 mg/kg/day × 1 month.